levodopa has been researched along with Amaurosis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bagheri, M; Rahat, F; Razeghinejad, MR | 1 |
Aviles, DH; Deputy, S; Kim, JS; Vives, MT | 1 |
Ardayfio, P; Chesselet, MF; Fleming, SM; Hwang, DY; Kim, H; Kim, KS; Moran-Gates, T; Tarazi, FI | 1 |
Bellastella, A; Colucci, CF; D'Alessandro, B; Lo Cicero, M | 1 |
Bellastella, A; Parlato, F; Sinisi, AA | 1 |
Fatranská, M; Jurcovicová, J; Németh, S; Vigas, M | 1 |
2 trial(s) available for levodopa and Amaurosis
Article | Year |
---|---|
Levodopa-carbidopa may improve vision loss in indirect traumatic optic neuropathy.
Topics: Adolescent; Adult; Blindness; Carbidopa; Chi-Square Distribution; Child; Dopamine Agents; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Methylprednisolone; Middle Aged; Optic Nerve Injuries; Treatment Outcome; Visual Acuity | 2010 |
Blindness impairs plasma growth hormone response to L-dopa but not to arginine.
Topics: Adult; Arginine; Blindness; Growth Hormone; Humans; Levodopa; Male; Middle Aged | 1990 |
4 other study(ies) available for levodopa and Amaurosis
Article | Year |
---|---|
Sudden blindness in a child with end-stage renal disease.
Topics: Anti-Inflammatory Agents; Blindness; Child, Preschool; Dopamine Agents; Humans; Hypotension; Kidney Failure, Chronic; Levodopa; Male; Methylprednisolone; Optic Nerve; Optic Neuropathy, Ischemic; Peritoneal Dialysis | 2004 |
3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Ataxia; Benserazide; Blindness; Corpus Striatum; Dopamine; Homeodomain Proteins; Levodopa; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Parkinsonian Disorders; Psychomotor Performance; Substantia Nigra; Transcription Factors | 2005 |
L-Dopa stimulated growth hormone release in the blind.
Topics: Aged; Blindness; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Time Factors | 1977 |
Diminished growth hormone secretion in blind males after L-dopa stimulation.
Topics: Administration, Oral; Adult; Blindness; Growth Hormone; Humans; Levodopa; Male; Radioimmunoassay | 1988 |